
Tina Wu, MD, MBA
Co-Founder & Chief Medical Officer, NOHO
Tina Wu, MD, MBA
Co-Founder & Chief Medical Officer, NOHOTina Wu, MD, MBA, is Co-Founder and Chief Medical Officer of NOHO. Double board-certified in Emergency Medicine and Obesity Medicine, she practices as an attending physician and associate professor at the Greater Los Angeles VA Healthcare System.
Prior to founding NOHO, Dr. Wu held senior leadership roles at Cloud Health Medical Systems, Sunrise Health, and Waltz Health. She spent more than a decade at NYU Langone Health, serving as Associate Chief of Service in Emergency Medicine and Medical Director of Kimmel Pavilion 11. During the COVID-19 pandemic, she led an acute care unit, reinforcing her commitment to high-acuity and underserved patient populations.
Dr. Wu earned dual BA and BS degrees from the University of Arizona, an MBA from Harvard Business School, and an MD from the UCLA David Geffen School of Medicine. She completed her Emergency Medicine residency at NYU Langone/Bellevue and fellowships in global health and national security. She has published extensively and was named by Time Magazine among the "200 Brightest, Most Industrious Minds in America."
- Undergraduate: BA/BS in Molecular and Cellular Biology and Psychology from University of Arizona
- Graduate: MBA from Harvard Business School
- Medical school: MD from University of California, Los Angeles (UCLA) David Geffen School of Medicine
- Residency: Emergency Medicine at NYU Langone Health/Bellevue Hospital Center
- Fellowships: National Security Education Fellowship, American Medical Student Association (AMSA) Global Health Fellowship
- Emergency Medicine
- Obesity Medicine
- Digital Health & Telemedicine
- Clinical Operations & Quality
The Use of an Emergency Department Expeditor to Improve Emergency Department CT Workflow: Initial ExperiencesGyftopoulos S, Wu TS, et al. | Journal of the American College of Radiology
"Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen...."Liao CL, Lee MY, Tyan YS, Kok LF, Wu TS, et al. | May 28, 2009, Journal of Translational Medicine 2009, 7:37
"Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas..."Han CP, Lee MY, Kok LF, Ruan A, Wu TS, Cheng YW, Tyan YS, Lin CY | Sep 2009, Int J Gynecol Pathol. 28(5):489-96
"Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing"Ian Larkin, Desmond Ang, Jonathan Steinhart, Tina Wu, et al. | May 2, 2017, JAMA, Vol. 317, No. 17, pp. 1785–1795
- Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyYao CC, Kok LF, Lee MY, Wang PH, Wu TS, Tyan YS, Cheng YW, Kung MF, Han CP | Sep 2009, Arch Gynecol Obstet. 280(3):405-13
- Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expressionKoo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, Ruan A, Chao KC, Han CP | Apr 14, 2009, J Transl Med
- Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyHan CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PH, Koo CL, Tyan YS | May 15, 2009, Arch Gynecol Obstet
- Acute Stroke Care in a New York City Comprehensive Stroke Center during the COVID-19 PandemicAgarwal S, Sher E, Wu TS, et al. | Journal of Stroke and Cerebrovascular Diseases
- Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyHan CP, Kok LF, Wang PH, Wu TS, Tyan YS, Cheng YW, Lee MY, Yang SF | Jun 2009, Mod Pathol. 22(6):797-806
- Comparing the scoring mechanisms of p16(INK4a) immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray studyKok LF, Lee MY, Tyan YS, Wu TS, Cheng YW, Kung MF, Wang PH, Han CP | May 6, 2009, Arch Gynecol Obstet
- The Medical Student Global Health Experience: Professional and Ethical ImplicationsWu TS, Shah S | 2008, J Med Ethics